R
Robert Austrian
Researcher at University of Pennsylvania
Publications - 54
Citations - 7473
Robert Austrian is an academic researcher from University of Pennsylvania. The author has contributed to research in topics: Pneumococcal infections & Streptococcus pneumoniae. The author has an hindex of 32, co-authored 54 publications receiving 7381 citations.
Papers
More filters
Journal ArticleDOI
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
Steven Black,Henry R. Shinefield,Bruce Fireman,Edwin Lewis,Paula Ray,John Hansen,Laura Elvin,Kathy M. Ensor,Jill G. Hackell,George R. Siber,Frank J. Malinoski,Dace V. Madore,Ih Chang,Robert Kohberger,Wendy J. Watson,Robert Austrian,Kathy Edwards +16 more
TL;DR: The Wyeth Lederle as discussed by the authors determined the efficacy, safety and immunogenicity of the CRM197 pneumococcal conjugate vaccine against invasive disease caused by vaccine serotypes and to determine the effectiveness of this vaccine against clinical episodes of otitis media.
Journal ArticleDOI
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
Eugene D. Shapiro,Anne T. Berg,Robert Austrian,Donna Schroeder,Valerie J. Parcells,Amy Margolis,Russell K. Adair,John D. Clemens +7 more
TL;DR: Polyvalent pneumococcal vaccine is efficacious in preventing invasive pneumitiscal infections in immunocompetent patients with indications for its administration and should be used more widely.
Journal ArticleDOI
Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.
JohnB Robbins,Robert Austrian,Lee Cj,Suresh C. Rastogi,Gerald Schiffman,J. Henrichsen,P. H. Mäkelä,Claire V. Broome,Richard R. Facklam,Tiesjema Rh +9 more
Journal Article
Prevention of pneumococcal pneumonia by vaccination.
Journal ArticleDOI
Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente.
Steven Black,Henry R. Shinefield,Roger Baxter,Robert Austrian,Laura Bracken,John Hansen,Edwin Lewis,Bruce Fireman +7 more
TL;DR: The PNCV7 vaccine is highly effective in reducing the burden of pneumococcal disease in children <5 years of age, and there is evidence of a herd effect as well as a decrease in the antibiotic resistant in strains causing disease.